Abstract

BackgroundThe World Health Organization (WHO) considers pregnant women to be a risk group for severe influenza disease. We conducted a systematic review to evaluate influenza disease incidence in pregnant women in order to inform estimates of influenza vaccine impact for low-resource countries.MethodsWe performed electronic literature searches, targeting studies on the following outcomes in pregnant women: attack rate, hospitalization rate, intensive care unit admission rate, mortality rate, and disability-adjusted life years lost. Only original studies published in peer-reviewed journals that had laboratory confirmation for influenza virus infection and included population-based incidence rates with denominator data were included. We summarized study characteristics in descriptive tables and outcome-specific Forest plots. We generated summary incidence rates using random effects models and assessed statistical heterogeneity by visual examination of Forest plots, and by χ2 and I2 tests.ResultsWe identified 1543 articles, of which nine articles met the study inclusion criteria. Five were case series, three were cohort studies, and one was a randomized controlled trial. Eight studies were from high-income countries, and one was from an upper middle-income country. Six studies reported results for pandemic influenza, and three reported seasonal influenza. Statistical heterogeneity was high for all outcomes, and methodologies and duration of surveillance varied considerably among studies; therefore, we did not perform meta-analyses.ConclusionsStudy quality was very low according to GRADE criteria. More data on influenza disease incidence in pregnant women, particularly in low- and middle-income countries and for seasonal influenza disease, are needed to inform public health decision-making.

Highlights

  • The World Health Organization (WHO) considers pregnant women to be a risk group for severe influenza disease

  • While the primary goal of these vaccine policies has been to protect pregnant women from severe outcomes related to influenza virus infection [4], many policy decisions to-date have been based on limited knowledge on the fundamental issue of incidence rates of influenza virus infection in pregnant women, including infections associated with hospital admission, intensive care unit (ICU) admission, death, and influenza-associated disability-adjusted life years (DALYs) lost

  • We did not identify any relevant studies that reported DALYs associated with influenza virus infection

Read more

Summary

Introduction

The World Health Organization (WHO) considers pregnant women to be a risk group for severe influenza disease. In 2012, the World Health Organization (WHO) updated its influenza vaccine position by recommending that countries considering the initiation or expansion of programmes for seasonal influenza vaccination should prioritize pregnant women over other high-risk groups [1]. This recommendation was based on evidence regarding influenza disease risk among pregnant women and their infants, influenza vaccine safety and. The anticipated impact that influenza vaccine programs would have on severe outcomes at a population level is unclear [9], and such data would be helpful to inform policy and investment decisions for maternal influenza immunization

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.